171 related articles for article (PubMed ID: 18648492)
1. Impairment of adolescent hippocampal plasticity in a mouse model for Alzheimer's disease precedes disease phenotype.
Hartl D; Rohe M; Mao L; Staufenbiel M; Zabel C; Klose J
PLoS One; 2008 Jul; 3(7):e2759. PubMed ID: 18648492
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice.
Roder S; Danober L; Pozza MF; Lingenhoehl K; Wiederhold KH; Olpe HR
Neuroscience; 2003; 120(3):705-20. PubMed ID: 12895511
[TBL] [Abstract][Full Text] [Related]
3. Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ42-Induced Pathways to Alzheimer's Disease Pathology.
Schedin-Weiss S; Nilsson P; Sandebring-Matton A; Axenhus M; Sekiguchi M; Saito T; Winblad B; Saido T; Tjernberg LO
J Alzheimers Dis; 2020; 75(1):321-335. PubMed ID: 32280097
[TBL] [Abstract][Full Text] [Related]
4. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease.
Martin B; Brenneman R; Becker KG; Gucek M; Cole RN; Maudsley S
PLoS One; 2008 Jul; 3(7):e2750. PubMed ID: 18648646
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23).
Diez M; Danner S; Frey P; Sommer B; Staufenbiel M; Wiederhold KH; Hökfelt T
Neurobiol Dis; 2003 Dec; 14(3):579-94. PubMed ID: 14678773
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
7. Presymptomatic alterations in energy metabolism and oxidative stress in the APP23 mouse model of Alzheimer disease.
Hartl D; Schuldt V; Forler S; Zabel C; Klose J; Rohe M
J Proteome Res; 2012 Jun; 11(6):3295-304. PubMed ID: 22568827
[TBL] [Abstract][Full Text] [Related]
8. MR elastography detection of early viscoelastic response of the murine hippocampus to amyloid β accumulation and neuronal cell loss due to Alzheimer's disease.
Munder T; Pfeffer A; Schreyer S; Guo J; Braun J; Sack I; Steiner B; Klein C
J Magn Reson Imaging; 2018 Jan; 47(1):105-114. PubMed ID: 28422391
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice.
Bondolfi L; Calhoun M; Ermini F; Kuhn HG; Wiederhold KH; Walker L; Staufenbiel M; Jucker M
J Neurosci; 2002 Jan; 22(2):515-22. PubMed ID: 11784797
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease.
Chang SH; Jung IS; Han GY; Kim NH; Kim HJ; Kim CW
Biochem Biophys Res Commun; 2013 Jan; 430(2):670-5. PubMed ID: 23211594
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis.
Takano M; Yamashita T; Nagano K; Otani M; Maekura K; Kamada H; Tsunoda S; Tsutsumi Y; Tomiyama T; Mori H; Matsuura K; Matsuyama S
Neurosci Lett; 2013 Feb; 534():85-9. PubMed ID: 23276639
[TBL] [Abstract][Full Text] [Related]
12. Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease.
Cuadrado-Tejedor M; Cabodevilla JF; Zamarbide M; Gómez-Isla T; Franco R; Perez-Mediavilla A
Curr Alzheimer Res; 2013 May; 10(4):390-405. PubMed ID: 23545067
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
14. p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease.
Ittner AA; Gladbach A; Bertz J; Suh LS; Ittner LM
Acta Neuropathol Commun; 2014 Oct; 2():149. PubMed ID: 25331068
[TBL] [Abstract][Full Text] [Related]
15. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
Chang KL; Wong LR; Pee HN; Yang S; Ho PC
Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
[TBL] [Abstract][Full Text] [Related]
16. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.
Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleus RNA sequencing reveals transcriptional changes of hippocampal neurons in APP23 mouse model of Alzheimer's disease.
Zhong S; Wang M; Zhan Y; Zhang J; Yang X; Fu S; Bi D; Gao F; Shen Y; Chen Z
Biosci Biotechnol Biochem; 2020 May; 84(5):919-926. PubMed ID: 31928331
[TBL] [Abstract][Full Text] [Related]
18. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
20. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
